ASPirin in Reducing Events in the Elderly
Description: Project Narrative The percentage of older individuals is rapidly increasing as a proportion of the U.S. and other developed countries. Low dose aspirin has the potential to increase the duration of their healthy active life by reducing the incidence of heart disease, stroke, dementia and cancer. This will be the first study in otherwise healthy individuals to determine whether the benefits of aspirin outweigh its side effects (particularly the risk of bleeding) among the older population.
Funder: National Institute on Aging
Funding type: cooperative_agreement
Funder scheme: U01
Start date: 2009-09-15
End date: 2019-04-30
Investigator: JOHN JAMES MCNEIL
Institution: HENNEPIN HEALTHCARE RESEARCH INSTITUTE
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Funded outputs count: 349
Funder award ID: U01AG029824
OpenAlex ID: G4158164718